Sheng-Mai San extracts attenuate heart injury in chronic intermittent hypoxia via suppressing oxidative damage and regulating glucose metabolism
Open Access
- 1 December 2022
- journal article
- Published by Elsevier BV in Pharmacological Research - Modern Chinese Medicine
Abstract
No abstract availableFunding Information
- National Natural Science Foundation of China (81973471)
This publication has 24 references indexed in Scilit:
- Identification of schisandrin as a vascular endothelium protective component in YiQiFuMai Powder Injection using HUVECs binding and HPLC-DAD-Q-TOF-MS/MS analysisJournal of Pharmacological Sciences, 2015
- A proteomic study of Shengmai injection's mechanism on preventing cardiac ischemia-reperfusion injury via energy metabolism modulationMolecular BioSystems, 2014
- Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathyBritish Journal of Pharmacology, 2014
- A network-based analysis of the types of coronary artery disease from traditional Chinese medicine perspective: Potential for therapeutics and drug discoveryJournal of Ethnopharmacology, 2014
- Cardiotonic Modulation in Heart Failure: Insights From Traditional Chinese MedicineJournal of the American College of Cardiology, 2013
- Screening and identifying the myocardial-injury protective ingredients from Sheng-Mai-SanPharmaceutical Biology, 2013
- Obstructive Sleep Apnea, Oxidative Stress and Cardiovascular Disease: Lessons from Animal StudiesOxidative Medicine and Cellular Longevity, 2013
- In search of new therapeutic targets and strategies for heart failure: recent advances in basic scienceThe Lancet, 2011
- Myocardial Fatty Acid Metabolism in Health and DiseasePhysiological Reviews, 2010
- Left ventricular dysfunction and associated cellular injury in rats exposed to chronic intermittent hypoxiaJournal of Applied Physiology, 2008